Sun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM, and what generic alternatives to SUN PHARM drugs are available?
SUN PHARM has five hundred and forty-eight approved drugs.
There are thirty-three US patents protecting SUN PHARM drugs. There are eighteen tentative approvals on SUN PHARM drugs.
There are three hundred and seventy-six patent family members on SUN PHARM drugs in fifty-eight countries and six hundred and sixteen supplementary protection certificates in nineteen countries.
Summary for Sun Pharm
International Patents: | 376 |
US Patents: | 33 |
Tradenames: | 354 |
Ingredients: | 328 |
NDAs: | 548 |
Patent Litigation for Sun Pharm: | See patent lawsuits for Sun Pharm |
PTAB Cases with Sun Pharm as petitioner: | See PTAB cases with Sun Pharm as petitioner |
Drugs and US Patents for Sun Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Ltd | FENOFIBRATE | fenofibrate | CAPSULE;ORAL | 201748-001 | Oct 31, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Industries | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 078081-003 | Jan 31, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 077926-002 | Sep 19, 2008 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Inds Inc | HALOG | halcinonide | CREAM;TOPICAL | 017556-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm | OMEPRAZOLE | omeprazole | TABLET, DELAYED RELEASE;ORAL | 207891-001 | Oct 12, 2018 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-002 | May 25, 2012 | 8,952,064 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-006 | Aug 15, 2014 | 9,078,925 | ⤷ Try a Trial |
Sun Pharm Industries | BACTRIM | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 017560-001 | Approved Prior to Jan 1, 1982 | RE28636 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-004 | May 25, 2012 | 8,952,064 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
➤ Subscribe | Tablets | 125 mg | ➤ Subscribe | 2018-07-23 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
International Patents for Sun Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Singapore | 10201709400V | ⤷ Try a Trial |
Mexico | 2018010395 | ⤷ Try a Trial |
Mexico | 363238 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2014062817 | ⤷ Try a Trial |
New Zealand | 572362 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1644019 | 122013000079 | Germany | ⤷ Try a Trial | PRODUCT NAME: LISDEXAMFETAMINE ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DESSEN, WIE L-LYSIN-D-AMPHETAMIN-MESYLAT; REGISTRATION NO/DATE: 86155.00.00 86156.00.00 86157.00.00 20130318; FIRST REGISTRATION: UK PL 08081/0050-2 20130201 |
2021328 | 2015C/059 | Belgium | ⤷ Try a Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CESSION |
1411900 | 2011/016 | Ireland | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
0240228 | SPC/GB97/086 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: QUETIAPINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY-ACCEPTABLE SALT; REGISTERED: UK 12619/0112 19970731; UK 12619/0113 19970731; UK 12619/0114 19970731 |
1746976 | C01746976/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: IRINOTECAN SUCROSOFAT; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 65994 25.07.2017 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.